Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.1.371

5'-CpG Island Promoter Hypermethylation of the CAV-1 Gene in Breast Cancer Patients of Kashmir  

Syeed, Nidda (Dept of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences)
Hussain, Firdous (Dept of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences)
Husain, Syed Akhtar (Dept of Biosciences Jamia Millia Islamia)
Siddiqi, Mushtaq A. (Dept of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.1, 2012 , pp. 371-376 More about this Journal
Abstract
Background: Caveolin-1 (CAV-1), encoding the structural component of cellular caveolae, is a suggested tumor suppressor gene involved in cell signalling. Aberrant promoter methylation of CAV-1 is associated with inactivation of expression. We previously observed CAV-1 mutations in breast cancers and therefore devised this study to examine the hypermethylation status of the promoter region of CAV-1 with reference to breast cancer progression and development. Methods: Hypermethylation status of CAV-1 was analyzed by methylation specific PCR. Loss of expression of the CAV-1 gene was further evaluated by semi-quantitative rt-PCR. Results: 28/130 (21.5%) breast cancer cases showed promoter hypermethylation with reduced CAV-1 expression levels when compared with adjacent normal breast tissue. CAV-1 gene hypermethylation was significantly related to menopausal status, histopathological grade and age. Conclusion: The rationale of our study is that CAV-1 gene is transcriptionally repressed in breast cancer cells due to hypermethylation. Our results reveal that promoter hypermethylation and loss of expression of the CAV-1 gene is an important alternative mechanism for inactivation of CAV-1 leading to complete gene silencing.
Keywords
Breast cancer; CAV-1; promoter hypermethylation; rt PCR; Kasmir;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Razani B, Schlegel A, Lisanti MP (2000).Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci, 113, 2103-9
2 Razani, B, XL Zhang, et al (2001)Caveolin-1 regulates transforming growth factor (TGF) beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem, 276, 6727-38.   DOI
3 Sipetic S, Petrović V, Milić Z, Vlajinac H (2004). Breast cancer incidence among women of Branicevo region in the period 1991-2000. Med Pregl, 57, 467-72.   DOI
4 Williams TM, Lisanti MP (2005). Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol, 288, 494-506.   DOI
5 Williams, TM, Cheung MW (2003). Loss of caveolins-1 gene expression accelerates the development of dysplastic mammary lesions in tumor prone transgenic mice. Mol Biol Cell, 14, 1027-42.   DOI
6 Koleske, D Baltimore, et al (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci, 92, 1381-5.   DOI
7 Nidda Syeed, Syed Akhtar Hussain, Safiya Abdullah, et al (2010) . Caveolin-1 Promotes Mammary Tumorigenesis: Mutational Profile of the Kashmiri Population. Asian Pacific J Cancer Prev, 11, 1-6.
8 Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE (1998) Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene, 16, 1391-7.   DOI
9 Longacre TA, Bartow SA (1986). A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol, 10, 382-93.   DOI
10 Meyer JS (1977). Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol, 8, 67-81.   DOI
11 Nishizuka S, Tamura G, Terashima M, Satodate R (1997). Commonly deleted region on the long armof chromosome 7 in differentiated adenocarcinoma of the stomach. Br J Cancer, 76, 1567-71.   DOI
12 Okamoto T, Schlegel A, Scherer PE, Lisanti MP. (1998). Caveolins,a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem, 273, 5419-22.   DOI
13 Park, SS, Kim JE, et al (2005). Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.Histopathology, 47, 625-30.   DOI
14 Parkin DM, Bray F, Ferlay J, Pisani P (2005).Global cancer statistics,2002. CA Cancer J Clin, 55, 74-108.   DOI
15 Pinilla, SM, Honrado E, et al (2006).Caveolin-1 expression is associated with a basal like phenotype in sporadic and hereditary breast cancer. Breast cancer Res Treat, 99, 85-90.   DOI
16 Han SY, DruckT, Huebner K (2003). Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer. Genomics, 81, 105-7.   DOI
17 Engelman JA, Zhang XL, Lisanti MP (1999). Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 50promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett, 448, 221-30.   DOI
18 Ferguson DJ, Anderson TJ (1981). Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer, 44, 177-81.   DOI
19 Goetz, JG, P Lajoie, et al (2008). Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev, 27, 715-35.   DOI
20 Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.   DOI
21 Hayashi K, Matsuda S, Machida K, et al (2001). Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res, 61, 2361-4.
22 Hnasko R, Lisanti MP (2003). The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv, 3, 445-?.   DOI
23 Huang CS, Chem HD, Chang KJ, et al (1999). Breast cancer risk associated with genotype polymorphism of the estrogenmetabolizing genes CYP 17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res, 59, 4870-5.
24 Huilt, T Bash, ONE AUTHOR, et al (2000). The cyclin D1 gene is transcriptionally repressed by caveolins-1. J Biol Chem, 275, 21203-9.   DOI
25 Issa JP, Vertino PM, Wu J, et al (1993). Increased cytosine DNAmethyltransferase activity during colon cancer progression. J Natl Cancer Inst, 85, 1235-40.   DOI
26 Chen, ST, Lin SY, et al (2004). Mutational, epigenetic and expressional analyses of caveolins-1 gene in breast cancers. Int J Mol Med, 14, 577-82.
27 Jones PA, Laird PW. (1999) Cancer epigenetics comes of age. Nat Genet, 21, 163-7.   DOI
28 Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP (1998). Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res, 58, 5489-94.
29 Baylin, Herman, Graff, et al (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 72, 141-96.